The pharmacoepidemiologic profile of a cardiology intensive care unit as a tool for standardization of a clinical pharmacy service

Authors

DOI:

https://doi.org/10.30968/rbfhss.2023.143.0934

Abstract

Objective: To describe the pharmacoepidemiologic profile of the cardiology intensive care unit (CICU) of a public university hospital as a way to contribute to planning, implementation and standardization of the clinical pharmacy service. Methods: A cross-sectional and retrospective study conducted at a public teaching hospital and developed in accordance with the recommendations of Strengthening the Reporting of Observational studies in Epidemiology (STROBE) statement. All medication orders made for patients admitted to the CICU (drug, dose, administration route, dosage) were included for analysis, in addition to data related to the patients' profile and to the hospitalizations (age, gender, hospitalization time). As a premise of analysis, indicators recommended by the literature on pharmacoepidemiology were used. The data were extracted from the hospital information system (Sistema de Informação Hospitalar, SIH) corresponding to the period from January 2015 to December 2019. They were subsequently compiled and analyzed using Microsoft Office Excel®, with analysis by means of descriptive statistics. Results: The study population consisted of 2,157 patients (51.3% male), with a mean age of 64 years old (SD ± 12.5) and mean hospitalization time of 4.5 days. 69.4% of the admissions were transferred to other hospitalization units, 24.6% were discharged from hospital and 6.0% evolved to death. The reasons for hospitalization were Acute Coronary Syndrome (44.6%), heart failure (9.7%), arrhythmias (4.9%), atrioventricular block (3.7%), valve stenosis (1.9%), cardiogenic shock (0.8%) and cardiac arrest with resuscitation (0.6%). The total number of medications prescribed was 175,573, with a daily rate of 96.2. A total of 468 medications were prescribed in different presentations, with Dipyrone 1g ampoule as the most prescribed item accounting for a total of 10,688 units (6.1%). Conclusion: The study contributed to characterizing the pharmacoepidemiologic profile of the cardiology intensive care unit with the purpose of presenting consistent data that will allow improving the clinical pharmacy service in its implementation and standardization.

Downloads

Download data is not yet available.

References

Polanczyk CA. Epidemiology of Cardiovascular Diseases in Brazil: The Truth Hidden in the Numbers. Arq Bras Cardiol. 2020;115(2):161-162. DOI: 10.36660/abc.20200793.

World Health Organization. (WHO). Global health estimates 2019: Life expectancy and leading causes of death and disability. World Health Organization. Geneva; 2019. Available in: https://www.who.int/data/gho/data/themes/mortality-and--global-healthestimates. Accessed in: 19 Oct 2022.

Koerich C, Erdmann AL. Gerenciando práticas educativas para o cuidado de enfermagem qualificado em cardiologia. Rev Bras Enferm. 2016; 69(5):872-880. DOI: 10.1590/0034-7167-

-0032.

Viana SSC, Arantes T, Ribeiro SCC. Interventions of the clinical pharmacist in an Intermediate Care Unit for elderly patients. Einstein (São Paulo). 2017; 15(3):283-288. DOI: 10.1590/S1679-45082017AO3894.

Rodrigues JP, Pereira LR. Farmácia Clínica em Ambiente Hospitalar: Perspectivas e Estratégias para Implementação. Journal of Applied Pharmaceutical Sciences. 2016;3(S1):7-10.

Conselho Federal de Farmácia. Resolução nº 675, de 31 de outubro de 2019: Regulamenta as atribuições do farmacêutico clínico em unidades de terapia intensiva, e dá outras providências. Available in: https://abmes.org.br/arquivos/legislacoes/Resolucao-CFF-675-2019-10-31.pdf. Accessed on: 22 Feb 2023.

Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F, Characterization of published randomized controlled trials assessing clinical pharmacy services around the World. Res Social Adm Pharm. 2017;13(1):201-208. DOI: 10.1016/j.sapharm.2016.01.003.

Souza Junior AKV, Marques MS. Pharmacoepidemiological Tracing of patients admitted to the Emergency Room of a Hospital in the interior of Minas Gerais. Research, Society and Development. 2021;10(7):e21910716519. DOI: 10.33448/rsd-v10i7.16519.

Leal LF, et al. Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study. Front Pharmacol. 2022 Jan;12:789872. DOI: 10.3389/fphar.2021.789872.

Adhikari K, Phukan S. Drug utilization pattern in cardiology intensive care unit in a tertiary health care institution. International Journal of Pharmaceutical Sciences and Research. 2018;9(9):3833-8.

Arora D, Vishwakarma K, Sharma M, Kaur N. Evaluation of Drug Utilization in Cardiovascular Disease: A Prospective Analysis. Eur J Mol Clin Med. 2022;9(7):3586-91.

Ashok P, Subramanian VT. Importance of Drug Utilization Evaluation Studies In Patient Health Care. Indian Journal of Pharmacy Practice. 2017;10(3):157-9. doi: 10.5530/ijopp.10.3.34.

WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology & WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to drug utilization research. Geneva: World Health Organization; 2003.

Ministério da Saúde. SIH/DATASUS. Available in: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sih/cnv/niuf.def. Accessed on: 7 Feb 2023.

Aguiar YM, Albuquerque JS, Alves MEM, et al. Perfil epidemiológico das internações e óbitos por doenças cardiovasculares no nordeste do Brasil antes e durante a pandemia do COVID-19. Research, Society and Development. 2022;11(14):e590111436850. DOI: 10.33448/rsd-v11i14.36850.

Santos, JR, Reis SCCAG, Reis MCS et al. Qualidade de vida de pacientes hospitalizados com doenças cardiovasculares: possibilidades de intervenção da terapia ocupacional. Rev Intern Bras Ter Ocup. 2017; 1(5):620-633. DOI: 10.47222/2526-3544.rbto9962.

Soares DS, Santos TS, Maier SRO, et al. Caracterização das vítimas de infarto do miocárdio admitidas em uma unidade coronariana. Ver Enferm Atenção à Saúde. 2019;8(2):98-106. DOI: 10.18554/reas.v8i2.3762.

Nogueira LS, Sousa RMC, Padilha KG, et al. Clinical characteristics and severity of patients admitted to public and private icus. Texto Contexto Enferm. 2012;21(1):59-67. DOI: 10.1590/S0104- 07072012000100007.

Barros ME, Araújo IG. Avaliação das intervenções Farmacêuticas em unidade de terapia intensiva de um hospital de ensino. Rev Bras Farm Hosp Serv Saúde. 2021;12(3):561-561. DOI: 10.30968/rbfhss.2021.123.0561.

Silva JLB, Pereira GRS, Kitayama MM, et al. Alternativa terapêutica para pacientes idosos, conforme padronização de um hospital de alta complexidade. Braz J Health Rev. 2020;3(6):19759-19772. DOI: 10.34119/bjhrv3n6-351.

Tinido PCF, Lopes-Ortiz MA. Avaliação das prescrições e possíveis interações medicamentosas em uma unidade de terapia intensiva adulto em um hospital da região Noroeste do Paraná. Braz J of Develop. 2020;6(9):73550-73559. DOI: 10.34117/bjdv6n9-712.

Doherty WL, Winter B. Prokinetic agents in critical care. Crit Care. 2003;7(3):206. DOI: 10.1186/cc1849.

Vincent JL. “Give Your Patient a Fast Hug (at Least) Once a Day*”. Crit Care Med. 2005 Jun;33(6):1225-1229. DOI: 10.1097/01.CCM.0000165962.16682.46.

Nascimento MMG, Wanderley LAS, Rosa MB, et al. Perfil de erros de dispensação de acordo com o sistema de dispensação adotado em um hospital público. Brazilian Journal of Health and Pharmacy. 2019;1(1):40-52. DOI: 10.29327/226760.1.1-5.

Ramos JP. Perfil farmacoterapêutico de pacientes, em uso de antimicrobianos, internados em hospital cardiológico de alta complexidade [Trabalho de Conclusão de Curso]. Universidade Federal do Amazonas. Itacoatiara. 2021.

Figueiredo RAM, Oliveira JT, Silva AMTC, et al. Enterococcus resistente à vancomicina: uma preocupação em expansão no ambiente hospitalar. J Infect Control. 2017;6(1):11-15.

Melo EM, Oliveira TMM, Marques AM, et al. Caracterização dos pacientes em uso de drogas vasoativas internados em unidade de terapia intensiva. Rev Fund Care Online. 2016:8(3):4898-4904. DOI: 10.9789/2175-5361.2016.v8i3.4898-4904.

Nicolau JC, Filho GSF, Petriz JL, et al. Brazilian Society of Cardiology guidelines on unstable angina and acute myocardial infarction without ST-segment elevation–2021. Arq Bras Cardiol. 2021;117(1):181-264. DOI: 10.36660/abc.20210180.

Freitas RF, Pinheiro MLP, Resille DP, et al. Administração de medicamentos por via parenteral: uma revisão. Conexão Ciência (Online). 2016;11(1):153-158. DOI: 10.24862/cco.v11i1.342.

Araújo APV, Melo DO. Substituição da via de administração de medicamentos: atuação do residente farmacêutico e economia de recursos. J Assist Farmac Farmacoecon. 2018;3(2):14-24 . DOI: 10.22563/2525-7323.2018.v3.n2.p.14-24.

Etelvino MAL, Santos ND, Aguiar BGC, et al. Segurança do paciente: uma análise do aprazamento de medicamentos. Enferm Foco. 2019;10(4):87-92. DOI: 10.21675/2357-707X.2019.v10.n4.2251.

Pires MAM, Santos PM. Erros de medicação em um hospital municipal do interior da Bahia. Uma análise do processo de prescrição e aprazamento. J Assist Farmac Farmacoecon. 2017;1(3):31-37. DOI: 10.22563/2525-7323.2016.

Published

2023-09-27

How to Cite

1.
PINHEIRO TO, SILVEIRA MA, ZONZINI FH, MENDES AM. The pharmacoepidemiologic profile of a cardiology intensive care unit as a tool for standardization of a clinical pharmacy service. Rev Bras Farm Hosp Serv Saude [Internet]. 2023Sep.27 [cited 2024Dec.21];14(3):934. Available from: https://rbfhss.org.br/sbrafh/article/view/934

Issue

Section

ORIGINAL ARTICLES